Clarity Pediatrics: Pediatric Chronic Care Company Raises $10 Million

Clarity Pediatrics: Pediatric Chronic Care Company Raises $10 Million

Clarity Pediatrics, a digital health company reimagining pediatric chronic care, announced the expansion of its pediatric ADHD platform and $10 million in seed funding led by Rethink Impact with participation from Homebrew and Maverick Ventures. This seed funding round also included investments from January Ventures, Vamos Ventures, Alumni Ventures and Citylight VC. And these institutional investors join a renowned set of angel investors who are healthcare leaders at CityBlock, Quartet, Livongo, Headspace (Ginger), Rock Health, Solv, and more.


This funding round supports Clarity Pediatrics’ launch of new clinical service lines, further development of its care platform, and geographic expansion.


About one in ten American children have ADHD, impacting their relationships, self-confidence, and performance at school. And the cornerstone of Clarity Pediatrics’ approach to ADHD care is Behavioral Parent Training (BPT), recommended by the American Academy of Pediatrics for families of children ages 5 to 12 with mild-moderate ADHD.


However, 80% of children with ADHD don’t have access to BPT, and most families wait over a year and pay $3,000 or more out of pocket to get access to ADHD treatment. And Clarity Pediatrics makes pediatric ADHD care ten times more accessible and 20x more affordable: families have access to next-day appointments, including ADHD diagnostic screening and medication-related services, and pay an average co-pay of $15 per session.


Through Clarity’s newly expanded ADHD care platform, families can now enroll in 12 months of virtual group therapy support via skill-building programs designed to address executive function challenges (e.g., homework organizational skills) and emotional dysregulation. Clarity also launched medication management for pediatric ADHD recently.


In under 18 months of providing clinical care to thousands of families in California, Clarity Pediatrics has established a reputation for delivering high-quality and effective ADHD care. And Clarity Pediatrics is in-network with all major commercial insurers in California, and over 400 pediatricians across the state have referred patients to Clarity, such as clinicians affiliated with all major California health systems.


KEY QUOTES:


“Our ADHD care model is transformative for families. Clarity Pediatrics integrates with referring pediatricians, so families stay close to their doctor and physicians get additional support. We’ve made the impossible now possible for thousands of families experiencing ADHD: affordable, expert diagnosis and multi-specialty treatment, coordinated on a single convenient platform, with no waitlists.”


– CEO and co-founder Christina LaMontagne; Before leading Clarity Pediatrics, LaMontagne was on the leadership team of two startups in the healthcare and fintech sectors that successfully reached >$100M in ARR and profitability


“Clarity’s rapid growth, coupled with exceptional parent feedback and patient outcomes, got us very excited. Dr. Alesandro Larrazabal and Christina LaMontagne really understand tech-enabled healthcare, and we were impressed by how quickly payers and providers partnered with them. I’ve known Christina for over ten years and can’t think of a more experienced and insightful leader to build a category-defining company that closes the pediatric chronic care gap for good.”


– Heidi Patel, Managing Partner at Rethink Impact


“For us, it’s essential to provide care to all families. In 2023, we welcomed our first Medicaid-enrolled patients and launched a Spanish-language pilot. The prevalence of pediatric chronic conditions has tripled, and we’re building our virtual care platform to expand beyond ADHD to other common pediatric chronic conditions like asthma, allergies, and obesity.” 


– Dr. Alesandro Larrazabal, who serves as Chief Medical Officer and co-founder; Dr. Larrazabal is an experienced pediatric specialist who trained at UCSF and Stanford, and, until recently, was a Medical Director building specialty care services at Kaiser Permanente